Efficacy and toxicity of capecitabine combined with intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with gastric cancer-Reference-Cited by-同舟云学术

Efficacy and toxicity of capecitabine combined with intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with gastric cancer

Published:2021-10-15 Issue:10 Volume:13 Page:1532-1543
ISSN:1948-5204
Container-title:World Journal of Gastrointestinal Oncology
language:
Short-container-title:WJGO

Author:

Wang Xin,Wang Wei-Hu,Wang Shu-Lian,Song Yong-Wen,Liu Yue-Ping,Tang Yuan,Li Ning,Liu Wen-Yang,Fang Hui,Li Ye-Xiong,Zhao Dong-Bing,Chi Yihebali,Yang Lin,Jin Jing

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,Oncology

Reference37 articles.

1. Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction

2. Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial

3. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

4. Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

5. A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiosensitizing effects of pyrogallol-loaded mesoporous or-ganosilica nanoparticles on gastric cancer by amplified ferroptosis;Frontiers in Bioengineering and Biotechnology;2023-04-18